SEURAT-1 - Towards the Replacement of in vivo Repeated Dose Systemic Toxicity Testing

In VitroPredictive Toxicity Testing

In vitro toxicity testing can range from using cell lines to detecting primitive stem cell populations in tissues explanted during animal studies. But, the most predictive in vitro toxicity testing is when primary human tissues are used for screening during the earliest stages of drug development. HemoGenix® has developed assays just for that purpose.
 

• Stem cell predictive toxicity assays
• Validated assays for specific tissues and applications
• Compare potential toxicity in different cell systems, tissues, and species with human primary cells
• Mechanism of action
• Cellular drug-drug interaction
• All stages of drug development, from high throughput screening to patient monitoring
• GLP or non-GLP

www.hemogenix.com